An Update on Acute Respiratory Distress Syndrome

Findings by Kwizera et al. further validate this approach. [5][6]6][7] The new global definition of ARDS includes high-flow nasal cannula therapy (HFNC) as a recognized modality for diagnosing nonintubated ARDS.Specifically, the definition stipulates that for nonintubated ARDS, patients should be receiving HFNC with a flow rate of at least 30 L/minute.This inclusion reflects the evolving landscape of ARDS management, where noninvasive methods like HFNC are becoming integral components of patient care.By incorporating HFNC into the diagnostic criteria, the definition aims to enhance early recognition and treatment of ARDS, particularly in settings where invasive mechanical ventilation may not be immediately available or preferred.The modified oxygenation criteria suits resource-limited settings but measurements require stable conditions, 30 minutes postchange.Also, SpO 2 :FiO 2 is invalid above 97% saturation, and pulse oximetry is unsuitable with hemoglobin abnormalities.Accurate readings need proper oximeter placement and waveform verification. 6 Acute RespiRAtoRy DistRess synDRome phenotypesRecent research has advanced our understanding of ARDS by identifying subphenotypes, especially hypoinflammatory intRoDuction Acute respiratory distress syndrome (ARDS) is a severe lung condition that causes acute inflammation, impaired gas exchange, and respiratory failure.First identified in 1967, ARDS continues to pose significant challenges in intensive care settings.It is characterized by diffuse alveolar and endothelial damage, leading to increased vascular permeability, lung edema, and hypoxemia.Globally, ARDS affects approximately 10% of patients admitted to ICUs and contributes to 23% of cases requiring mechanical ventilation.Mortality rates remain high, ranging between 30 and 45%. 1,2esearch advancements with emerging insights into its pathophysiology, phenotypes, and novel management strategiessuch as improved ventilatory techniques and pharmacologic approaches-underscore the importance of ongoing studies.Tools like artificial intelligence are opening new avenues for personalized care and better outcomes.